Microsoft Corporation (NASDAQ:MSFT): Citigroup continues to view Windows 8 as a positive catalyst for Microsoft shares and says it remains a buyer of the stock. The firm believes that below $40, Microsoft shares are pricing in declines in Windows.
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH): Deutsche Bank lowered its price target for shares of Anthera Pharmaceuticals to $4 from $14 after the company’s VISTA-16 trial failed. However, the firm sees upside in Anthera from current levels given the likelihood of success for the PEARL-SC trial in lupus. Deutsche keeps a Buy rating on Anthera.
Harley-Davidson, Inc. (NYSE:HOG): Citigroup’s dealer checks indicate Harley-Davidson’s U.S. retail sales are up 16%-18% January through early March. Citi raised its price target for Harley-Davidson shares to $50 from $46 citing the company’s solid sales momentum, but keeps a Hold rating on the name.
Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM): Roth Capital removed Peregrine from its Focus List due to increased risk surrounding vabituximab’s clinical development. Price target lowered to $3.30 from $7.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Regeneron added to U.S. 1 List at BofA/Merrill
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org